Professional Documents
Culture Documents
Prostate Cancer Screening: Current Understanding and Management Adeep Thumar MD June 11, 2015
Prostate Cancer Screening: Current Understanding and Management Adeep Thumar MD June 11, 2015
Prostate Cancer Screening: Current Understanding and Management Adeep Thumar MD June 11, 2015
Adeep Thumar MD
It is influenced by androgen
Traditionally 4 ng/ml was used but 25% of prostate cancers were detected below 4
Rapidly rising psa (psa velocity), elevated psa in comparison to prostate size (psa
density) are markers
– PSA density >0.15 for pts with psa between total values of 4 and 10
– PSA velocity- >0.75 ng/ml/year for psa 4-10. Some say even lower threshold for lower psa.
– % free psa- cancer pts have lower free psa as psa is complexed
What is a biopsy
What is biopsy
• Traditionally performed by transrectal ultrasound
• Performed in office
• Tolerated well
• Prostate MRI
May be useful in patients for repeat biopsies
May be useful in patients on surveillance
No standardization in interpretation at this time
Guidelines- US Preventative Task Force
• 2012- Panel gave PSA screening grade D
• Recommends against Prostate Cancer Screening in general population
• They do not have recommendation for people of certain ethnicity known for
higher incidence of prostate cancer
• Prior recommendation was there was insufficient data for general population
but definitely no benefit for individuals over age of 75.
• Same task force in 2009 that recommended against mammography screening for
breast cancer which was later rescinded
• Conclusions were made based on large trial data that had contamination.
Guidelines- American Cancer Society